Mereo BioPharma Group plc
MREO
$2.33
$0.031.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 22.65% | -129.69% | -600.00% | 25.88% | 4.80% |
| Total Depreciation and Amortization | -2.49% | 0.00% | -5.17% | 21.15% | 54.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -184.62% | 3,399.62% | -11.58% | -1.75% | 376.65% |
| Change in Net Operating Assets | 140.75% | -115.06% | 118.40% | -505.93% | 4.28% |
| Cash from Operations | -38.75% | -382.78% | -1.93% | 13.59% | 48.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -67.06% | -100.00% |
| Cash from Investing | -- | -- | -- | -67.06% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -100.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -16.24% | -426.87% | -- | -100.00% |
| Cash from Financing | -- | -107.51% | 69,722.39% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -174.91% | 220.04% | -112.65% | -105.41% | 126.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.87% | -172.25% | 666.74% | -4.62% | 72.88% |